Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 840

1.

pH balance and lactic acid increase in the vitreous body of diabetes mellitus patients.

Mieno H, Marunaka Y, Inaba T, Kojima K, Yoneda K, Nagata K, Sotozono C.

Exp Eye Res. 2019 Sep 3;188:107789. doi: 10.1016/j.exer.2019.107789. [Epub ahead of print]

PMID:
31491425
2.

Multicenter survey of sutureless 27-gauge vitrectomy for primary rhegmatogenous retinal detachment: a consecutive series of 410 cases.

Shinkai Y, Oshima Y, Yoneda K, Kogo J, Imai H, Watanabe A, Matsui Y, Suzuki K, Sotozono C; 27G Vitrectomy Study Group.

Graefes Arch Clin Exp Ophthalmol. 2019 Sep 2. doi: 10.1007/s00417-019-04448-2. [Epub ahead of print]

PMID:
31478083
3.

Outcomes More Than 2 Years After Meniscal Repair for Radial/Flap Tears of the Posterior Lateral Meniscus Combined With Anterior Cruciate Ligament Reconstruction.

Tsujii A, Yonetani Y, Kinugasa K, Matsuo T, Yoneda K, Ohori T, Hamada M.

Am J Sports Med. 2019 Aug 30:363546519869955. doi: 10.1177/0363546519869955. [Epub ahead of print]

PMID:
31469576
4.

Functional assessment of tandem coronary artery stenosis by intracoronary optical coherence tomography-derived virtual fractional flow reserve: a case series.

Okuya Y, Seike F, Yoneda K, Takahashi T, Kishi K, Hiasa Y.

Eur Heart J Case Rep. 2019 Jun 1;3(2). pii: ytz087. doi: 10.1093/ehjcr/ytz087.

5.

Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer.

Yoneda K, Kuwata T, Kanayama M, Mori M, Kawanami T, Yatera K, Ohguri T, Hisaoka M, Nakayama T, Tanaka F.

Br J Cancer. 2019 Sep;121(6):490-496. doi: 10.1038/s41416-019-0541-3. Epub 2019 Aug 7.

PMID:
31388183
6.

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey.

Gregg JP, Li T, Yoneda KY.

Transl Lung Cancer Res. 2019 Jun;8(3):286-301. doi: 10.21037/tlcr.2019.04.14. Review.

7.

Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.

Xiao W, Ma W, Wei S, Li Q, Liu R, Carney RP, Yang K, Lee J, Nyugen A, Yoneda KY, Lam KS, Li T.

J Hematol Oncol. 2019 Jul 26;12(1):83. doi: 10.1186/s13045-019-0764-z.

8.

Salvage surgery combined with descending aorta resection for lung cancer.

Kanayama M, Ichiki Y, Mori M, Matsumiya H, Nabe Y, Taira A, Shinohara S, Kuwata T, Takenaka M, Hirai A, Imanishi N, Yoneda K, Ikushima E, Yasutsune T, Nishimura Y, Tanaka F.

Surg Case Rep. 2019 Jul 22;5(1):114. doi: 10.1186/s40792-019-0675-9.

9.

Treatment of Non-small Cell Lung Cancer with EGFR-mutations.

Yoneda K, Imanishi N, Ichiki Y, Tanaka F.

J UOEH. 2019;41(2):153-163. doi: 10.7888/juoeh.41.153.

10.

High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.

Xiao W, Ma W, Wei S, Li Q, Liu R, Carney RP, Yang K, Lee J, Nyugen A, Yoneda KY, Lam KS, Li T.

J Hematol Oncol. 2019 Jun 10;12(1):56. doi: 10.1186/s13045-019-0740-7. Erratum in: J Hematol Oncol. 2019 Jul 26;12(1):83.

11.

Prognostic factors of advanced or postoperative recurrent non-small cell lung cancer targeted with immune check point inhibitors.

Ichiki Y, Taira A, Chikaishi Y, Matsumiya H, Mori M, Kanayama M, Nabe Y, Shinohara S, Kuwata T, Takenaka M, Oka S, Hirai A, Imanishi N, Yoneda K, Kuroda K, Fujino Y, Tanaka F.

J Thorac Dis. 2019 Apr;11(4):1117-1123. doi: 10.21037/jtd.2019.04.41.

12.

Daily growth increments in otoliths of wild-caught honmoroko Gnathopogon caerulescens.

Kikko T, Ishizaki D, Yodo T, Aino S, Kuwamura K, Okamoto H, Nemoto M, Yoneda K, Oue N, Sakai A, Fujioka Y, Kai Y, Sato T, Nakayama K.

J Fish Biol. 2019 Aug;95(2):668-672. doi: 10.1111/jfb.14008. Epub 2019 May 29.

PMID:
31090069
13.

Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection.

Shimizu Y, Yoneda K, Shirasago Y, Suzuki T, Tada M, Ishii-Watabe A, Sugiyama K, Suzuki T, Wakita T, Yagi K, Kondoh M, Fukasawa M.

Biochem Biophys Res Commun. 2019 Jun 30;514(3):785-790. doi: 10.1016/j.bbrc.2019.05.019. Epub 2019 May 9.

PMID:
31079928
14.

Prominence of Pairing in Inclusive (p,2p) and (p,pn) Cross Sections from Neutron-Rich Nuclei.

Paul N, Obertelli A, Bertulani CA, Corsi A, Doornenbal P, Rodriguez-Sanchez JL, Authelet G, Baba H, Calvet D, Château F, Chen S, Delbart A, Gheller JM, Giganon A, Gillibert A, Isobe T, Lapoux V, Matsushita M, Momiyama S, Motobayashi T, Niikura M, Otsu H, Péron C, Peyaud A, Pollacco EC, Roussé JY, Sakurai H, Santamaria C, Sasano M, Shiga Y, Steppenbeck D, Takeuchi S, Taniuchi R, Uesaka T, Wang H, Yoneda K, Ando T, Arici T, Blazhev A, Browne F, Bruce AM, Carroll R, Chung LX, Cortés ML, Dewald M, Ding B, Dombradi Z, Flavigny F, Franchoo S, Giacoppo F, Górska M, Gottardo A, Hadynska-Klek K, Korkulu Z, Koyama S, Kubota Y, Jungclaus A, Lee J, Lettmann M, Linh BD, Liu J, Liu Z, Lizarazo C, Louchart C, Lozeva R, Matsui K, Miyazaki T, Moschner K, Nagamine S, Nakatsuka N, Nita C, Nishimura S, Nobs CR, Olivier L, Ota S, Patel Z, Podolyák Z, Rudigier M, Sahin E, Saito TY, Shand C, Söderström PA, Stefan IG, Sumikama T, Suzuki D, Orlandi R, Vaquero V, Vajta Z, Werner V, Wimmer K, Wu J, Xu Z.

Phys Rev Lett. 2019 Apr 26;122(16):162503. doi: 10.1103/PhysRevLett.122.162503.

PMID:
31075035
15.

Difficulty of treatment for pleural epithelioid hemangioendothelioma: a report of a case.

Takenaka M, Ichiki Y, Nabe Y, Tsuda Y, Kuwata T, Chikaishi Y, Hirai A, Imanishi N, Yoneda K, Tanaka F.

Gen Thorac Cardiovasc Surg. 2019 May 2. doi: 10.1007/s11748-019-01135-1. [Epub ahead of print]

PMID:
31049818
16.

Fenestration without rib resection for postoperative bronchopleural fistula.

Kanayama M, Ichiki Y, Yoshimatsu K, Takeda Y, Kusanagi K, Ishida T, Mori M, Matsumiya H, Nabe Y, Taira A, Shinohara S, Kuwata T, Takenaka M, Hirai A, Imanishi N, Yoneda K, Tanaka F.

Surg Case Rep. 2019 May 2;5(1):70. doi: 10.1186/s40792-019-0629-2.

17.

78Ni revealed as a doubly magic stronghold against nuclear deformation.

Taniuchi R, Santamaria C, Doornenbal P, Obertelli A, Yoneda K, Authelet G, Baba H, Calvet D, Château F, Corsi A, Delbart A, Gheller JM, Gillibert A, Holt JD, Isobe T, Lapoux V, Matsushita M, Menéndez J, Momiyama S, Motobayashi T, Niikura M, Nowacki F, Ogata K, Otsu H, Otsuka T, Péron C, Péru S, Peyaud A, Pollacco EC, Poves A, Roussé JY, Sakurai H, Schwenk A, Shiga Y, Simonis J, Stroberg SR, Takeuchi S, Tsunoda Y, Uesaka T, Wang H, Browne F, Chung LX, Dombradi Z, Franchoo S, Giacoppo F, Gottardo A, Hadyńska-Klęk K, Korkulu Z, Koyama S, Kubota Y, Lee J, Lettmann M, Louchart C, Lozeva R, Matsui K, Miyazaki T, Nishimura S, Olivier L, Ota S, Patel Z, Şahin E, Shand C, Söderström PA, Stefan I, Steppenbeck D, Sumikama T, Suzuki D, Vajta Z, Werner V, Wu J, Xu ZY.

Nature. 2019 May;569(7754):53-58. doi: 10.1038/s41586-019-1155-x. Epub 2019 May 1.

PMID:
31043730
18.

Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors.

Gong J, Gregg JP, Ma W, Yoneda K, Moore EH, Daly ME, Zhang Y, Williams MJ, Li T.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):297-301. doi: 10.6004/jnccn.2019.7291.

PMID:
30959466
19.

[Autoimmune pancreatitis with bowel obstruction caused by proximal jejunal stricture:a case report].

Oyama G, Tomita M, Matsuo T, Inada Y, Osaka H, Kiriyama M, Yoneda K, Takagawa K, Tsuji H.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(3):256-264. doi: 10.11405/nisshoshi.116.256. Japanese.

PMID:
30853679
20.

How Robust is the N=34 Subshell Closure? First Spectroscopy of ^{52}Ar.

Liu HN, Obertelli A, Doornenbal P, Bertulani CA, Hagen G, Holt JD, Jansen GR, Morris TD, Schwenk A, Stroberg R, Achouri N, Baba H, Browne F, Calvet D, Château F, Chen S, Chiga N, Corsi A, Cortés ML, Delbart A, Gheller JM, Giganon A, Gillibert A, Hilaire C, Isobe T, Kobayashi T, Kubota Y, Lapoux V, Motobayashi T, Murray I, Otsu H, Panin V, Paul N, Rodriguez W, Sakurai H, Sasano M, Steppenbeck D, Stuhl L, Sun YL, Togano Y, Uesaka T, Wimmer K, Yoneda K, Aktas O, Aumann T, Chung LX, Flavigny F, Franchoo S, Gašparić I, Gerst RB, Gibelin J, Hahn KI, Kim D, Koiwai T, Kondo Y, Koseoglou P, Lee J, Lehr C, Linh BD, Lokotko T, MacCormick M, Moschner K, Nakamura T, Park SY, Rossi D, Sahin E, Sohler D, Söderström PA, Takeuchi S, Törnqvist H, Vaquero V, Wagner V, Wang S, Werner V, Xu X, Yamada H, Yan D, Yang Z, Yasuda M, Zanetti L.

Phys Rev Lett. 2019 Feb 22;122(7):072502. doi: 10.1103/PhysRevLett.122.072502.

PMID:
30848641
21.

Airway transcriptomic profiling after bronchial thermoplasty.

Liao SY, Linderholm AL, Yoneda KY, Kenyon NJ, Harper RW.

ERJ Open Res. 2019 Feb 18;5(1). pii: 00123-2018. doi: 10.1183/23120541.00123-2018. eCollection 2019 Feb.

22.

Predictive factors of postoperative survival among patients with pulmonary neuroendocrine tumor.

Ichiki Y, Matsumiya H, Mori M, Kanayama M, Nabe Y, Taira A, Shinohara S, Kuwata T, Takenaka M, Hirai A, Imanishi N, Yoneda K, Noguchi H, Shimajiri S, Fujino Y, Nakayama T, Tanaka F.

J Thorac Dis. 2018 Dec;10(12):6912-6920. doi: 10.21037/jtd.2018.11.115.

23.

Percutaneous endoscopic gastrostomy for enteral nutrition: a 5-year clinical experience with 324 patients.

Toh Yoon EW, Yoneda K, Nishihara K.

Minerva Gastroenterol Dietol. 2019 Mar;65(1):20-29. doi: 10.23736/S1121-421X.18.02535-7.

PMID:
30676011
24.

Post-treatment with JP-1302 protects against renal ischemia/reperfusion-induced acute kidney injury in rats.

Shimokawa T, Tsutsui H, Miura T, Takama M, Hayashi K, Nishinaka T, Terada T, Yoneda K, Yamagata M, Yukimura T.

J Pharmacol Sci. 2019 Mar;139(3):137-142. doi: 10.1016/j.jphs.2018.12.008. Epub 2018 Dec 31.

25.

Return to work after surgical treatment for malignant pleural mesothelioma: report of a case.

Takenaka M, Ichiki Y, Taira A, Shinohara S, Kuwata T, Hirai A, Imanishi N, Yoneda K, Tsubota N, Tanaka F.

Gen Thorac Cardiovasc Surg. 2019 Jan 12. doi: 10.1007/s11748-019-01064-z. [Epub ahead of print]

PMID:
30637565
26.

First Observation of ^{20}B and ^{21}B.

Leblond S, Marqués FM, Gibelin J, Orr NA, Kondo Y, Nakamura T, Bonnard J, Michel N, Achouri NL, Aumann T, Baba H, Delaunay F, Deshayes Q, Doornenbal P, Fukuda N, Hwang JW, Inabe N, Isobe T, Kameda D, Kanno D, Kim S, Kobayashi N, Kobayashi T, Kubo T, Lee J, Minakata R, Motobayashi T, Murai D, Murakami T, Muto K, Nakashima T, Nakatsuka N, Navin A, Nishi S, Ogoshi S, Otsu H, Sato H, Satou Y, Shimizu Y, Suzuki H, Takahashi K, Takeda H, Takeuchi S, Tanaka R, Togano Y, Tuff AG, Vandebrouck M, Yoneda K.

Phys Rev Lett. 2018 Dec 28;121(26):262502. doi: 10.1103/PhysRevLett.121.262502.

PMID:
30636115
27.

Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma.

Yoneda K, Kuwata T, Chikaishi Y, Mori M, Kanayama M, Takenaka M, Oka S, Hirai A, Imanishi N, Kuroda K, Ichiki Y, Ohnaga T, Tanaka F.

Cancer Sci. 2019 Feb;110(2):726-733. doi: 10.1111/cas.13895. Epub 2019 Jan 8.

28.

Neutrophilia and hyperamylasemia in patients with immediate food allergy.

Kimura M, Ito Y, Shimomura M, Yoneda K, Naito C, Adachi Y, Meguro T.

Pediatr Int. 2019 Jan;61(1):23-30. doi: 10.1111/ped.13728.

PMID:
30402929
29.

Extraction of the Landau-Migdal Parameter from the Gamow-Teller Giant Resonance in ^{132}Sn.

Yasuda J, Sasano M, Zegers RGT, Baba H, Bazin D, Chao W, Dozono M, Fukuda N, Inabe N, Isobe T, Jhang G, Kameda D, Kaneko M, Kisamori K, Kobayashi M, Kobayashi N, Kobayashi T, Koyama S, Kondo Y, Krasznahorkay AJ, Kubo T, Kubota Y, Kurata-Nishimura M, Lee CS, Lee JW, Matsuda Y, Milman E, Michimasa S, Motobayashi T, Muecher D, Murakami T, Nakamura T, Nakatsuka N, Ota S, Otsu H, Panin V, Powell W, Reichert S, Sakaguchi S, Sakai H, Sako M, Sato H, Shimizu Y, Shikata M, Shimoura S, Stuhl L, Sumikama T, Suzuki H, Tangwancharoen S, Takaki M, Takeda H, Tako T, Togano Y, Tokieda H, Tsubota J, Uesaka T, Wakasa T, Yako K, Yoneda K, Zenihiro J.

Phys Rev Lett. 2018 Sep 28;121(13):132501. doi: 10.1103/PhysRevLett.121.132501.

PMID:
30312098
30.

Specific protein-labeling and ligand-binding position analysis with amidopyrene probes as LDI MS tags.

Watanabe R, Hu Y, Iio K, Yoneda K, Hattori A, Arai A, Kigoshi H, Kita M.

Org Biomol Chem. 2018 Oct 31;16(42):7883-7890. doi: 10.1039/c8ob02222d.

PMID:
30306182
31.

Inhibition of catechol-O-methyltransferase in the cynomolgus monkey by opicapone after acute and repeated administration.

Kitajima T, Mizote S, Bonifácio MJ, Umemura T, Yoneda K, Moser P, Soares-da-Silva P, Tanaka M.

Neuropharmacology. 2018 Dec;143:282-288. doi: 10.1016/j.neuropharm.2018.10.001. Epub 2018 Oct 2.

32.

Erratum: Persistence of the Z=28 Shell Gap Around ^{78}Ni: First Spectroscopy of ^{79}Cu [Phys. Rev. Lett. 119, 192501 (2017)].

Olivier L, Franchoo S, Niikura M, Vajta Z, Sohler D, Doornenbal P, Obertelli A, Tsunoda Y, Otsuka T, Authelet G, Baba H, Calvet D, Château F, Corsi A, Delbart A, Gheller JM, Gillibert A, Isobe T, Lapoux V, Matsushita M, Momiyama S, Motobayashi T, Otsu H, Péron C, Peyaud A, Pollacco EC, Roussé JY, Sakurai H, Santamaria C, Sasano M, Shiga Y, Takeuchi S, Taniuchi R, Uesaka T, Wang H, Yoneda K, Browne F, Chung LX, Dombradi Z, Flavigny F, Giacoppo F, Gottardo A, Hadyńska-Klęk K, Korkulu Z, Koyama S, Kubota Y, Lee J, Lettmann M, Louchart C, Lozeva R, Matsui K, Miyazaki T, Nishimura S, Ogata K, Ota S, Patel Z, Sahin E, Shand C, Söderström PA, Stefan I, Steppenbeck D, Sumikama T, Suzuki D, Werner V, Wu J, Xu Z.

Phys Rev Lett. 2018 Aug 31;121(9):099902. doi: 10.1103/PhysRevLett.121.099902.

PMID:
30230867
33.

Bronchial Thermoplasty: A Decade of Experience: State of the Art.

Tan LD, Yoneda KY, Louie S, Hogarth DK, Castro M.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):71-80. doi: 10.1016/j.jaip.2018.08.017. Epub 2018 Sep 5.

34.

A novel bifunctional aspartate kinase-homoserine dehydrogenase from the hyperthermophilic bacterium, Thermotoga maritima.

Ohshida T, Koba K, Hayashi J, Yoneda K, Ohmori T, Ohshima T, Sakuraba H.

Biosci Biotechnol Biochem. 2018 Dec;82(12):2084-2093. doi: 10.1080/09168451.2018.1511365. Epub 2018 Sep 1.

PMID:
30175674
35.

Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer.

Shinohara S, Ichiki Y, Fukuichi Y, Honda Y, Kanayama M, Taira A, Nabe Y, Kuwata T, Takenaka M, Oka S, Chikaishi Y, Hirai A, Imanishi N, Kuroda K, Yoneda K, Noguchi H, Tanaka F.

J Thorac Dis. 2018 Jul;10(7):E526-E531. doi: 10.21037/jtd.2018.06.83. No abstract available.

36.

Outcomes of patients undergoing surgery for thymic carcinoma: a single-center experience.

Nabe Y, Ichiki Y, Fukuichi Y, Mori M, Honda Y, Kanayama M, Taira A, Shinohara S, Kuwata T, Takenaka M, Chikaishi Y, Oka S, Hirai A, Tashima Y, Kuroda K, Imanishi N, Yoneda K, Tanaka F.

J Thorac Dis. 2018 Jul;10(7):4283-4286. doi: 10.21037/jtd.2018.06.36.

37.

The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study.

Mieno H, Yoneda K, Yamazaki M, Sakai R, Sotozono C, Fukui M.

BMJ Open Ophthalmol. 2018 Jul 23;3(1):e000130. doi: 10.1136/bmjophth-2017-000130. eCollection 2018.

38.

Mediating effects of perceived stress on the relationship of positivity with negative and positive affect.

Horiuchi S, Tsuda A, Yoneda K, Aoki S.

Psychol Res Behav Manag. 2018 Aug 2;11:299-303. doi: 10.2147/PRBM.S164761. eCollection 2018.

39.

Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl.

Iwamura R, Tanaka M, Okanari E, Kirihara T, Odani-Kawabata N, Shams N, Yoneda K.

J Med Chem. 2018 Aug 9;61(15):6869-6891. doi: 10.1021/acs.jmedchem.8b00808. Epub 2018 Jul 30.

PMID:
29995405
40.

Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys.

Fuwa M, Toris CB, Fan S, Taniguchi T, Ichikawa M, Odani-Kawabata N, Iwamura R, Yoneda K, Matsugi T, Shams NK, Zhang JZ.

J Ocul Pharmacol Ther. 2018 Sep;34(7):531-537. doi: 10.1089/jop.2017.0146. Epub 2018 Jul 10.

PMID:
29989843
41.

Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC).

Yoneda K, Imanishi N, Ichiki Y, Tanaka F.

J UOEH. 2018;40(2):173-189. doi: 10.7888/juoeh.40.173. Review.

42.

Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumor.

Wakai K, Utsumi T, Yoneda K, Oka R, Endo T, Yano M, Fujimura M, Kamiya N, Sekita N, Mikami K, Sugano I, Hiruta N, Suzuki H.

Int J Clin Oncol. 2018 Oct;23(5):957-964. doi: 10.1007/s10147-018-1299-y. Epub 2018 May 26.

PMID:
29804156
43.

The clinical value of circulating tumour cells (CTCs) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer.

Hashimoto M, Tanaka F, Yoneda K, Takuwa T, Kuroda A, Matsumoto S, Okumura Y, Kondo N, Tsujimura T, Nakano T, Hasegawa S.

J Thorac Dis. 2018 Mar;10(3):1569-1577. doi: 10.21037/jtd.2018.03.05.

44.

A liquid biopsy in primary lung cancer.

Yoneda K, Imanishi N, Ichiki Y, Tanaka F.

Surg Today. 2019 Jan;49(1):1-14. doi: 10.1007/s00595-018-1659-2. Epub 2018 Apr 11. Review.

PMID:
29644440
45.

Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung.

Imanishi N, Hirai A, Yoneda K, Shimajiri S, Kuwata T, Tashima Y, Takeuchi M, Iwai Y, Ichiki Y, Tanaka F.

J Surg Oncol. 2018 Jun;117(7):1563-1569. doi: 10.1002/jso.25041. Epub 2018 Mar 30.

PMID:
29601633
46.

Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.

Hashimoto M, Tanaka F, Yoneda K, Takuwa T, Matsumoto S, Okumura Y, Kondo N, Tsujimura T, Nakano T, Hasegawa S.

J Thorac Dis. 2018 Jan;10(1):298-306. doi: 10.21037/jtd.2017.12.56.

47.

Podoplanin: An emerging cancer biomarker and therapeutic target.

Krishnan H, Rayes J, Miyashita T, Ishii G, Retzbach EP, Sheehan SA, Takemoto A, Chang YW, Yoneda K, Asai J, Jensen L, Chalise L, Natsume A, Goldberg GS.

Cancer Sci. 2018 May;109(5):1292-1299. doi: 10.1111/cas.13580. Review.

48.

Coping as a mediator of the relationship between stress mindset and psychological stress response: a pilot study.

Horiuchi S, Tsuda A, Aoki S, Yoneda K, Sawaguchi Y.

Psychol Res Behav Manag. 2018 Mar 1;11:47-54. doi: 10.2147/PRBM.S150400. eCollection 2018.

49.

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung.

Imanishi N, Yoneda K, Taira A, Ichiki Y, Sato N, Hisaoka M, Tanaka F.

Surg Case Rep. 2018 Mar 9;4(1):19. doi: 10.1186/s40792-018-0430-7.

50.

Capture of mesothelioma cells with 'universal' CTC-chip.

Yoneda K, Chikaishi Y, Kuwata T, Ohnaga T, Tanaka F.

Oncol Lett. 2018 Feb;15(2):2635-2640. doi: 10.3892/ol.2017.7619. Epub 2017 Dec 14.

Supplemental Content

Loading ...
Support Center